Affordable and Safe Prescription Drug Importation Act
- Last Action
- 2/28/2017
Actions
- 2017-02-28Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2017-02-28Introduced in Senate
CRS Summary
As of 2017-02-28 (00)
Affordable and Safe Prescription Drug Importation Act
This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain prescription drugs from Canada. The FDA, within two years, may permit the importation of prescription drugs from other countries.
The bill establishes a process for certifying foreign sellers—a licensed foreign pharmacy or foreign wholesale distributor.
Cosponsors (20)
- Cory Booker (D-NJ)
- Bob Casey (D-PA)
- Martin Heinrich (D-NM)
- Angus King (I-ME)
- Sheldon Whitehouse (D-RI)
- Amy Klobuchar (D-MN)
- Kirsten Gillibrand (D-NY)
- Sherrod Brown (D-OH)
- John Reed (D-RI)
- Al Franken (D-MN)
- Tammy Baldwin (D-WI)
- Maggie Hassan (D-NH)
- TOM UDALL (D-NM)
- Debbie Stabenow (D-MI)
- Jeanne Shaheen (D-NH)
- Maria Cantwell (D-WA)
- Chris Van Hollen (D-MD)
- Richard Blumenthal (D-CT)
- Joseph Manchin (D-WV)
- Jeff Merkley (D-OR)
Subjects
- Administrative law and regulatory procedures
- Canada
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Government information and archives
- Government studies and investigations
- Prescription drugs
- Trade restrictions
- User charges and fees
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.